BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3534099)

  • 21. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
    Glasky MS; Reading CL
    Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
    Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
    Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
    Power DA; Gerkis V; d'Apice AJ
    Hum Antibodies Hybridomas; 1990; 1(1):34-41. PubMed ID: 2103351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient preparation of human monoclonal antibody-secreting heterohybridomas using peripheral B lymphocytes cultured in the CD40 system.
    Darveau A; Chevrier MC; Néron S; Delage R; Lemieux R
    J Immunol Methods; 1993 Feb; 159(1-2):139-43. PubMed ID: 7680365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.
    Lane HC; Shelhamer JH; Mostowski HS; Fauci AS
    J Exp Med; 1982 Jan; 155(1):333-8. PubMed ID: 6976416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.
    Glassy MC; Handley HH; Hagiwara H; Royston I
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6327-31. PubMed ID: 6604917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
    Denis KA; Wall R; Saxon A
    J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro immunization for the production of antigen-specific lymphocyte hybridomas.
    Borrebaeck CA
    Scand J Immunol; 1983 Jul; 18(1):9-12. PubMed ID: 6192490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].
    Seregina TM; Mekshenkov MI
    Tsitologiia; 1986 Sep; 28(9):976-80. PubMed ID: 3798564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenic capacity of macrophage hybridomas.
    Tzehoval E; Dagan S; Eisenbach L; Atsmon J; Feldman M
    Eur J Immunol; 1989 Jan; 19(1):89-96. PubMed ID: 2465907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of three methods for production of human hybridomas secreting autoantibodies.
    Niedbala WG; Stott DI
    Hybridoma; 1998 Jun; 17(3):299-304. PubMed ID: 9708833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human hybridoma generation by hypo-osmolar electrofusion: characterization of human monoclonal antibodies to Schistosoma mansoni parasite antigens.
    Klock G; Wisnewski AV; el-Bassiouni EA; Ramadan MI; Gessner P; Zimmermann U; Kresina TF
    Hybridoma; 1992 Aug; 11(4):469-81. PubMed ID: 1398684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of leucine methyl ester for the generation of hybridomas producing monoclonal antibodies specific to tumor-associated antigens.
    Seo N; Egawa K
    Cancer Immunol Immunother; 1994 Apr; 38(4):277-80. PubMed ID: 8168123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential generation of IgG-producing human hybridomas against human tumor cells.
    Hagiwara H; Nagao J
    J Immunol Methods; 1990 Dec; 135(1-2):263-71. PubMed ID: 2125620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells.
    Dubois AR; Buerckert JP; Sinner R; Faison WJ; Molitor AM; Muller CP
    Hum Antibodies; 2016 Jun; 24(1-2):1-15. PubMed ID: 27472868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Generation and characteristics of hybridomas producing monoclonal antibodies to the surface antigen of hepatitis B virus].
    Kushch AA; Momot AM; Shumaĭ EP; Bukrinskaia AG; Anan'ev VA
    Vopr Virusol; 1987; 32(4):448-51. PubMed ID: 3318133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histocompatible miniature pig (d/d haplotype): generation of hybridomas secreting A or M monoclonal antibody.
    Kaeffer B; Bottreau E; Marcon D; Olivier M; Lantier I; Salmon H
    Hybridoma; 1991 Dec; 10(6):731-44. PubMed ID: 1667778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.